-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VZ/2YrPYA+XaYWeZBpMf1JEyTl/EdiCZyega7PRUr7MdPHcMYZ22C+JqpzCFAYkf xO92ZHD/YZQWfXrfpjhhbw== 0000920148-03-000090.txt : 20030402 0000920148-03-000090.hdr.sgml : 20030402 20030402134947 ACCESSION NUMBER: 0000920148-03-000090 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030331 FILED AS OF DATE: 20030402 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: LAI GOLDMAN MYLA CENTRAL INDEX KEY: 0001168581 RELATIONSHIP: OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: 430 S SPRING STREET CITY: BURLINGTON STATE: NC ZIP: 27215 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133757370 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 03636176 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 4 1 fm4mlg033103.txt MARCH FORM 4 ------------------------------ OMB APPROVAL [ ] Check this box if no longer ------------------------------ subject to Section 16. Form 4 or OMB Number 3235-0287 Form 5 obligations may continue. Expires: January 31, 2005 See Instruction 1(b). Estimated average burden hours per response ....... 0.5 ------------------------------ U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Lai-Goldman, Myla P. - -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o Laboratory Corporation of America Holdings, 430 South Spring Street - -------------------------------------------------------------------------------- (Street) Burlington, North Carolina 27215 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Laboratory Corporation of America Holdings ("LH") - -------------------------------------------------------------------------------- 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) - -------------------------------------------------------------------------------- 4. Statement for Month/Day/Year March 31, 2003 - -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Day/Year) - -------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) [_] Director [_] 10% Owner [X] Officer (give title below) [_] Other (specify below) Executive Vice President, Chief Scientific Officer, and Medical Director -------------------------------------------------------------------------- - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check applicable line) [X] Form filed by One Reporting Person [_] Form filed by more than One Reporting Person - -------------------------------------------------------------------------------- ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
5. Amount of 6. 4. Securities Owner- Securities Acquired (A) Beneficially ship 2A. 3. or Disposed of (D) Owned Form: 7. 2. Deemed Transaction (Instr. 3, 4 and 5) Following Direct Nature of Transaction Execution Code ------------------------- Reported (D) or Indirect 1. Date Date, if (Instr. 8) (A) Transaction(s) Indirect Beneficial Title of Security (Month/Day any (Month/ ------------ Amount or Price (Instr. 3 (I) Ownership (Instr. 3) Year) Day/Year) Code V (D) and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock (1) 3/31/03 D 6,641 D $30.00 91,407.2098(2) D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 2,000 (3) I By Children - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
(1) Pursuant to a plan in compliance with Rule 10b5-1 under the Securities Exchange Act of 1934. (2) Amount shown reflects a 2-for-1 stock split effective on May 10, 2002. (3) Dr. Lai-Goldman disclaims beneficial ownership of the 2,000 shares of common stock held in her daughter's name. (Over) SEC 1475(8-02) FORM 4 (continued) Table II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
5. Number of 6. 3A. Derivative Date 2. 3. Deemed 4. Securities Exercisable and 1. Conversion Trans- Execution Transaction Acquired (A) or Expiration Date Title of or Exercise action Date, if Code Disposed of (D) (Month/Day/Year) Derivative Price of Date any (Instr.8) (Instr. 3, 4 and 5) ----------------------- Security Derivative (Month/ (Month/ ---------- ------------------- Date Expiration (Instr. 3) Security Day/Year) Day/Year) Code V (A) (D) Exercisable Date - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ==================================================================================================================================== 7. Title and Amount 9. 10. of Underlying Number of Ownership Form Securities Derivative of Derivative 11. (Instr. 3 and 4) 8. Securities Securities Nature of - ---------------------------- Price of Beneficially Owned Beneficially Indirect Amount or Derivative Following Reported Owned at End Beneficial Number of Security Transaction(s) of Month Ownership Title Shares (Instr. 5) (Instr. 4) (Instr. 4) (Instr. 4) - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- - ---------------------------------------------------------------------------------------------------------------- ================================================================================================================
Explanation of Responses: /s/ Bradford T. Smith March 31, 2003 - --------------------------------------------- ----------------------- **Signature of Reporting Person Date Bradford T. Smith, Attorney-in-Fact for Myla P. Lai-Goldman Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 2 -----END PRIVACY-ENHANCED MESSAGE-----